Published Paper Details:

Cardiovascular (CV) disease is a major cause of morbidity and mortality in the developing and the developed world. Mortality from CV disease had plateaued in the recent years raising concerning alarms about the sustained efficacy of available preventive and treatment options. Sacubitril/Valsartan is a much needed therapeutic advance in the avenue oh CV disease.It may help to live longer and lower chance of having to go to hospital for heart failure. This product contain 2 medications: Sacubitral and Valsartan. Sacubitril belongs to a class of drug called Neprilysin inhibitors and Valsartan belongs to a class of drug called Angiotensin receptor blockers ( ARBs). They work by relaxing blood vessels, so that blood can flow more easily, which makes it easier for our heart to pump blood to our body. This product should not be taken with ACE inhibitors (such as captopril, enalapril), since our risk of serious side effects may increase. Do not take this product for at least 36 hours before or after taking ACE.